SPONGE: Trial for Retractor Sponge Evaluation in Laparoscopic Colorectal Surgery

Sponsor
St. Antonius Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03334383
Collaborator
(none)
188
1
2
69
2.7

Study Details

Study Description

Brief Summary

Laparoscopic surgery of the distal colon and rectum requires surgery with an appropriate field of view. A commonly used technique to create a clear exposure is the steep Trendelenburg position in which the patient is positioned in an angle of 15 to 40 degrees with the head down using the effect of gravity to retract the small intestine. This method is associated with haemostatic changes caused by the cranial shift of abdominal organs and blood. Recently, a cellulose compressed sponge was developed as intraoperative retractor, with the aim to keep the small intestines aside while the patient remains in a horizontal position. The safety of the sponge is secured with CE marking. The retractor sponge ensures a clear surgical field and potentially prevents haemostatic instability by avoiding Trendelenburg position. A pilot study in the St Antonius Hospital Nieuwegein has shown that use of the sponge might be associated with shorter hospital stay.

Condition or Disease Intervention/Treatment Phase
  • Device: Sponge
N/A

Detailed Description

Objective: We study the efficacy of the retractor sponge in laparoscopic colorectal surgery to reduce hospital stay in patients operated for a malignancy. Secondary objectives are duration of surgery, blood-loss, use of diuretics as volume therapy (during surgery as wells as during total hospital stay), postoperative hypoxemia and peri- and postoperative complications.

Study design: Randomized controlled trial, nested within a prospective cohort according to the 'cohort multiple randomized controlled trial' (cmRCT) design.

Study population: Patients with colorectal cancer who undergo laparoscopic surgery, and who have given informed consent to be offered experimental interventions within the PICNIC project. Patient who require open surgery or patients with benign colorectal diseases are excluded for this study.

Intervention: Intraoperative use of the retractor sponge versus usual care, i.e. the Trendelenburg position.

Main study parameters/endpoints: The primary endpoint is length of hospital stay. Secondary endpoints are duration of surgery, blood-loss, use of diuretics (during surgery as wells as during total hospital stay), postoperative hypoxemia and peri- and postoperative surgical, pulmonary and cardiac complications.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The study will be conducted according to the cohort multiple Randomized Controlled Trial (cmRCT) design. Within the PICNIC cohort, we will identify all patients who are eligible for the experimental intervention (use of the sponge) and who have given informed consent to be invited for future experimental interventions. From this sub cohort, we will randomly select a group of patients to whom we will offer surgery with use of the retractor sponge, which they can accept or decline. Eligible patients from the sub cohort who were not randomly selected will undergo standard treatment, i.e. surgery in Trendelenburg position. We do not expect adverse events in patients in the intervention arm, besides dysfunction of the sponge, after which conversion to standard treatment (Trendelenburg position) needs to take place.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
188 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized Controlled Trial to Evaluate the Effect of a Retractor Sponge in Postoperative Hospital Stay in Laparoscopic Colorectal Surgery in Patients With Malignancy
Actual Study Start Date :
Jan 1, 2015
Anticipated Primary Completion Date :
Jun 1, 2020
Anticipated Study Completion Date :
Oct 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sponge group

Patients offered surgery with the retractor sponge

Device: Sponge
Compressed cellulose sponge for use in laparoscopic surgery to retract the intestines from the surgical field.
Other Names:
  • Endoractor, Kawamoto corporation (Osaka, Japan)
  • No Intervention: Control group

    Patients receiving standard care: surgery in Trendelenburg position

    Outcome Measures

    Primary Outcome Measures

    1. Postoperative hospital stay (days) [Up to 4 weeks]

      Based on a discharge checklist

    Secondary Outcome Measures

    1. Operation time [Up to 4 hours]

      minutes

    2. Blood-loss peroperative [During surgery time]

      ml

    3. Diuretics peroperative and postoperative [Up to 4 weeks (during hospital stay)]

      mg

    4. Postoperative hypoxemia [Up to 1 week]

      O2 saturation

    5. Peri- and postoperative surgical complications [Up to 4 weeks]

      number

    6. Pulmonary complications. [Up to 4 weeks]

      number

    7. Cardiac complications [Up to 4 weeks]

      number

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 95 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    • Participant in the PICNIC project (METC 12-510)

    • Informed consent obtained for being offered experimental interventions within the PICNIC project

    • Informed consent obtained for questionnaires on patient reported outcomes within the PICNIC project

    • Planned for laparoscopic surgery of distal colorectal cancer in St. Antonius Hospital

    Exclusion Criteria:
    • Planned for open colorectal surgery

    • Surgery for benign colorectal diseases

    • Emergency colorectal surgery

    • Inadequate understanding of the Dutch language in speech and/or writing

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Antonius Hospital Nieuwegein Utrecht Netherlands 3430EM

    Sponsors and Collaborators

    • St. Antonius Hospital

    Investigators

    • Principal Investigator: Anke B Smits, MD, St. Antonius Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    dr. A.B. Smits, Dr. A.M. Smits, St. Antonius Hospital
    ClinicalTrials.gov Identifier:
    NCT03334383
    Other Study ID Numbers:
    • 49877
    • 49877
    First Posted:
    Nov 7, 2017
    Last Update Posted:
    May 31, 2019
    Last Verified:
    May 1, 2019
    Keywords provided by dr. A.B. Smits, Dr. A.M. Smits, St. Antonius Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 31, 2019